10.1007/s40204-020-00147-y

Enhanced brain targeting efficiency using 5-FU (fluorouracil) lipid–drug conjugated nanoparticles in brain cancer therapy

Show Details XML
  • Gajanan Shinde1,
  • Sangita Shiyani1,
  • Santosh Shelke*2,
  • Rashmi Chouthe2,
  • Deepak Kulkarni2,
  • Khushboo Marvaniya1,
  1. Department of Pharmaceutics, Parul Institute of Pharmacy, Faculty of Pharmacy, Parul University, Vadodara, Gujarat, 391760, IN
  2. Department of Pharmaceutics, Srinath College of Pharmacy, Aurangabad, Maharashtra, 431136, IN

Published in Issue 2020-11-30

How to Cite

Shinde, G., Shiyani, S., Shelke, S., Chouthe, R., Kulkarni, D., & Marvaniya, K. (2020). Enhanced brain targeting efficiency using 5-FU (fluorouracil) lipid–drug conjugated nanoparticles in brain cancer therapy. Progress in Biomaterials, 9(4 (December 2020). https://doi.org/10.1007/s40204-020-00147-y
Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Abstract The present investigation was aimed to synthesize, optimize, and characterize lipid/drug conjugate nanoparticles for delivering 5-fluorouracil (5-FU) to treat brain cancer. The Box–Behnken design was used to optimize the formulation, evaluate the particle size, entrapment efficiency, morphology, in vitro drug release study, and stability profiles. The in vitro performance was executed using cell line studies. The in vivo performance was carried out for pharmacokinetic studies, sterility test, biodistribution studies, and distribution lipid–drug conjugated (LDC) nanoparticles in the brain. Particle size, zeta potential, entrapment efficiency, and morphology of the optimized formulation demonstrated desirable results. In vitro release pattern showed initial fast release, followed by sustained release up to 48 h. Cytotoxic effects of blank stearic acid nanoparticles, LDC nanoparticles, and 5-FU solution on human glioma cell lines U373 MG cell showed more cytotoxicity by LDC-NPs compared to others. The values reported for LDC (AUC = 19.37 ± 0.09 µg/mL h and VD 2.4 ± 0.24 mL) and pure drug (AUC = 8.37 ± 0.04 µg/mL h and VD = 5.24 ± 0.29 mL) indicate higher concentrations of LDC in systemic circulation, while pure 5-FU was found to be largely available in tissue rather than blood circulation. The t 1/2 for LDC represents an approximate rise by ninefold, while MRT (12.10 ± 0.44 h) denotes 12-fold rise than pure 5-FU indicating the prolonged circulation of LDC. Free 5-FU concentration in the brain was maximum (5.24 ± 0.01 μg/g) after 3 h, while for the optimized formulation of LDC it was twofold greater estimated as 11.52 ± 0.32 μg/g. In conclusion, the efficiency of 5-FU to treat the brain is increased when it is formulated with LDC nanoparticles.

Keywords

  • 5-Fluorouracil (5-FU),
  • Lipid–drug conjugate nanoparticles (LDC nanoparticles),
  • U373MG,
  • Brain cancer,
  • Cytotoxic study,
  • Stearic acid

References

  1. Agrawal et al. (2017) Formulation, physicochemical characterization and in vitro evaluation of human insulin-loaded microspheres as potential oral carrier (pp. 125-136) https://doi.org/10.1007/s40204-017-0072-z
  2. Ahmadi and Adibhesami (2017) The effect of silver nanoparticles on wounds contaminated with Pseudomonas aeruginosa in mice: an experimental study 16(2) (pp. 661-669)
  3. Ahn et al. (2012) Formation pathways of magnetite nanoparticles by coprecipitation method (pp. 6069-6076) https://doi.org/10.1021/jp211843g
  4. Akrami et al. (2016) Tuning the anticancer activity of a novel pro-apoptotic peptide using gold nanoparticle platforms (pp. 31030-31042) https://doi.org/10.1038/srep31030
  5. Arya et al. (2011) Enhanced antiproliferative activity of herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy (pp. 859-870) https://doi.org/10.1016/j.nano.2011.03.009
  6. Augustine and Rajarathinam (2012) Synthesis and characterization of silver nanoparticles and its immobilization on alginate coated sutures for the prevention of surgical wound infections and the in vitro release studies (pp. 205-212) https://doi.org/10.1007/2Fs40204-016-0060-8
  7. Bala et al. (2004) PLGA nanoparticles in drug delivery: the state of the art (pp. 387-422) https://doi.org/10.1615/critrevtherdrugcarriersyst.v21.i5.20
  8. Balaji and Gothandam (2016) Cytotoxic effect on cancerous cell lines by biologically synthesized silver nanoparticles (pp. 1-8) https://doi.org/10.1590/1678-4324-2016150529
  9. Banerjee and Ravishankar (2017) Aspergillus fischeri mediated biosynthesis of gold nanoparticles and their beneficially comparative effect on normal and cancer cell lines (pp. 1-10) https://doi.org/10.1007/s40204-019-0106-9
  10. Beduneau et al. (2007) Active targeting of brain tumours using nanocarriers (pp. 4947-4967) https://doi.org/10.1016/j.biomaterials.2007.06.011
  11. Brigger et al. (2002) Nanoparticles in cancer therapy and diagnosis (pp. 631-651) https://doi.org/10.1016/j.addr.2012.09.006
  12. Cai (2020) A nanostrategy for efficient imaging-guided antitumor therapy through a stimuli-responsive branched polymeric prodrug (pp. 1-13) https://doi.org/10.1002/advs.201903243
  13. Calvo et al. (1997) Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers (pp. 125-132) https://doi.org/10.1002/(SICI)1097-4628(19970103)63:1%3C125::AID-APP13/3E3.0.CO;2-4
  14. Carneiro et al. (2012) Formation of ion pairing as an alternative to improve encapsulation and anticancer activity of all-trans retinoic acid loaded in solid lipid nanoparticles (pp. 6011-6020) https://doi.org/10.2147/ijn.s38953
  15. Chauhan and Jain (2013) Strategies for advancing cancer nanomedicine (pp. 958-962) https://doi.org/10.1038/2Fnmat3792
  16. Chen et al. (2015) Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles (pp. 14080-14092) https://doi.org/10.1039/C5NR03527A
  17. Chen (2020) Multistimuli-responsive PEGylated polymeric bioconjugate-based nano-aggregate for cancer therapy (pp. 1-43) https://doi.org/10.1016/j.cej.2019.123543
  18. Dikpati et al. (2012) Targeted drug delivery to CNS using nanoparticles (pp. 79-191) https://doi.org/10.15171/2Fapb.2016.044
  19. Din et al. (2017) Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors (pp. 7291-7309) https://doi.org/10.2147/2FIJN.S146315
  20. Dinda et al. (2012) Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumorcells https://doi.org/10.2147/ijn.s32694
  21. Foldbjerg et al. (2011) Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549 85(7) (pp. 743-750) https://doi.org/10.1007/s00204-010-0545-5
  22. Fukumoto et al. (2001) Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain (pp. 100-106) https://doi.org/10.1007/s002130100871
  23. Gindy and Prud’homme (2009) Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy (pp. 865-878) https://doi.org/10.1517/17425240902932908
  24. Gupta and Gupta (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications (pp. 3995-4021) https://doi.org/10.1016/j.biomaterials.2004.10.012
  25. Heath and Davis (2008) Nanotechnology and Cancer (pp. 251-265) https://doi.org/10.1146/annurev.med.59.061506.185523
  26. Hiremath et al. (2018) Synergistic delivery of 5-fluorouracil and curcumin using human serum albumin-coated iron oxide nanoparticles by folic acid targeting (pp. 297-306) https://doi.org/10.1007/s40204-018-0104-3
  27. Hu et al. (2002) Synthesis and characterization of chitosan-poly (acrylic acid) nanoparticles (pp. 3193-3201) https://doi.org/10.1016/S0142-9612(02)00071-6
  28. Inkielewicz-Stepniak et al. (2014) Pharmacological and toxicological effects of coexposure of human gingival fibroblasts to silver nanoparticles and sodium fluoride (pp. 1677-1687) https://doi.org/10.2147/2FIJN.S59172
  29. Jain et al. (2008) Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging (pp. 4012-4021) https://doi.org/10.1016/2Fj.biomaterials.2008.07.004
  30. Jitendar et al. (2013) Poly (ethylene)-glycol conjugated solid lipid nanoparticles of noscapine improve biological half-life, brain delivery and efficacy in glioblastomacells (pp. 492-503) https://doi.org/10.1016/j.nano.2012.10.003
  31. Koopaei et al. (2014) Docetaxel loaded PEG-PLGA nanoparticle: optimized drug loading, in-vitro cytotoxicity and in vivo antitumor effect (pp. 819-833)
  32. Kratz (2008) Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles (pp. 171-183) https://doi.org/10.1016/j.jconrel.2008.05.010
  33. Lin et al. (2016) Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy (pp. 1420-1425) https://doi.org/10.3109/10717544.2015.1066902
  34. Liu et al. (2009) Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel (pp. 330-338) https://doi.org/10.1016/j.biomaterials.2009.09.036
  35. Locatelli and Franchini (2012) Biodegradable PLGA-b-PEG polymeric nanoparticles: synthesis, properties, and nanomedical applications as drug delivery system https://doi.org/10.1007/s11051-012-1316-4
  36. Loira-Pastoriza et al. (2014) Delivery strategies for sustained drug release in the lungs (pp. 81-91) https://doi.org/10.1016/j.addr.2014.05.017
  37. Longley et al. (2003) 5-Fluorouracil: mechanisms of action and clinical strategies (pp. 330-338) https://doi.org/10.1038/nrc1074
  38. Ma and Mumper (2013) Paclitaxel nano-delivery systems: a comprehensive review https://doi.org/10.4172/2157-7439.1000164
  39. Meng et al. (2011) Conjugates of folic acids with BSA-coated quantum dots for cancer cell targeting and imaging by single-photon and two-photon excitation (pp. 117-123) https://doi.org/10.1007/s00775-010-0709-z
  40. Mudshinge et al. (2011) Nanoparticles: emerging carriers for drug delivery (pp. 129-141) https://doi.org/10.1016/j.jsps.2011.04.001
  41. Nerkar et al. (2012) Fabrication of lipospheres for paclitaxel and assessment of in vitro cytotoxicity against U373 cancer cell lines (pp. 117-130)
  42. Pan et al. (2020) Dendronized-polymer disturbing cells’ stress protection by targeting metabolism leads to tumor vulnerability (pp. 1-10) https://doi.org/10.1002/adma.201907490
  43. Prabhjot et al. (2014) Brain delivery of intranasal in situ gel of nanoparticulated polymeric carriers containing antidepressant drug: behavioral and biochemical assessment (pp. 1-12) https://doi.org/10.3109/2F1061186X.2014.994097
  44. Ramesh et al. (2006) Development of 5-fluorouracil loaded poly (acrylamide-comethylmethacrylate)novel core-shell microspheres: in vitro release studies (pp. 55-62) https://doi.org/10.1016/j.ijpharm.2006.06.020
  45. Raut et al. (2010) The formulation, characterization and in vivo evaluation of a magnetic carrier for brain delivery of NIR dye https://doi.org/10.3109/10717544.2012.714812
  46. Sharma et al. (2012) Synthesis of cytarabine lipid drug conjugate for treatment of meningeal leukemia: development, characterization and in vitro cell line studies (pp. 928-937) https://doi.org/10.1166/jbn.2012.1464
  47. Shelke et al. (2016) Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies https://doi.org/10.3109/08982104.2015.1132232
  48. Shelke et al. (2016) Thermoreversible nanoethosomal gel for the intranasal delivery of Eletriptan hydrobromide https://doi.org/10.1007/s10856-016-5713-6
  49. Shinde et al. (2020) Mometasone furoate-loaded aspasomal gel for topical treatment of psoriasis: formulation, optimization, in vitro and in vivo performance https://doi.org/10.1080/09546634.2020.1789043
  50. Shrivastava et al. (2007) Characterization of enhanced antibacterial effects of novel silver nanoparticles (pp. 225103-225112) https://doi.org/10.1088/0957-4484/18/22/225103
  51. Sun et al. (2006) Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI (pp. 550-557) https://doi.org/10.1002/jbm.a.30781
  52. Wang et al. (2004) Polymer coating/encapsulation of nanoparticles using a supercritical anti-solvent process (pp. 85-99) https://doi.org/10.1016/S0896-8446(03)00011-1
  53. Yang et al. (2012) Biodegradable solid lipid nanoparticle flocculates for pulmonary delivery of insulin (pp. 834-842) https://doi.org/10.1166/jbn.2012.1429
  54. Yang et al. (2014) Preparation of folic acid-conjugated, doxorubicin-loaded, magnetic bovine serum albumin nanospheres and their antitumor effects in vitro and in vivo https://doi.org/10.2147/2FIJN.S67210
  55. Zhang et al. (2020) Glycodendron/pyropheophorbide-a (Ppa)-functionalized hyaluronic acid as a nanosystem for tumor photodynamic therapy (pp. 1-14) https://doi.org/10.1016/j.carbpol.2020.116749
  56. Zheng et al. (2019) Tunable hydrophile–lipophile balance for manipulating structural stability and tumor retention of amphiphilic nanoparticles (pp. 1-10) https://doi.org/10.1002/adma.201901586
  57. Zhuang et al. (2012) Solidlipidnanoparticlesof anticancer drugs against MCF-7 cell line and a murine breast cancer model (pp. 925-929)